Planning to live tweet the #Angel AGM. In case anyone is interested.

Company description in the quoted tweet thread. Image
In 2016, were among the first BFSI to launch digital KYC.
Nse active clients has grown at cagr of 23% between 2014 and 2021.
Lots of mention of artificial intelligence and machine learning. Now an established Fintech broker.
671 million trades in fy21.
3.8x growth in margin funding book yoy.
At least 35% of profit will be shared as dividends with shareholders on quarterly basis.
Today's genZ will be tomorrow's wealth creators. Want to onboard them early.
Will start the process of seeking regulatory approval for amc. Will launch low cost smart beta ETF.
Q1. Why did the ipo come after 25 years?
Q2. How many staff affected by covid ?
Q3. Investor would like to see building
Q4. Share of revenue from distribution
Q5. Will we enter crypto?
Q6. What is the future roadmap for next 25 years ?
Ans :
1. It takes time for company to scale up and give profits. When we saw reliance jio launch we saw that a structural change and so we decided to ipo.
2 & 3. We do have a large corporate office in mumbai. Structure of office required for digital player is very different. We have adopted a culture of work from anywhere. Our employees can work from anywhere.
5. Waiting for regulatory approval. will enter after regulations are clear.

We do have research and advisory service. But given that we have 50 lakh clients we can't do it physically.
6.look forward to becoming a large fintech player.
4. Distribution income contributed 155 million. Average interest rate Charged to client for margin funding is 16% pa.
Shareholder 2:
7. I have a 3-1 account in icici. Brokerage are higher there but I am happy with bank backed broker.
8. Develop something good in Calcutta.
9. Other brokerage bouses take 15 rs. Why do you charge 20 rs.
10. Other brokerage firms charge 9%, why do you charge 18%?
11. Please give gifts to all shareholders who spoke at agm. I can pay for it if needed. I don't need it, but it is a memento.
9. We give research, do lot of app development. Pricing is according to the costs. Ones charging 5 and 10 rs won't be able to provide service.
10. Our rates are similar to competitors for margin funding. This is different from loan against shares product.
Shareholder 3:
12. Impact of covid on our business. Did we fire any employees or salary cut. Any cost cutting measures?
13. My angel account was shifted from Chennai to Mumbai to Bangalore to delhi.
Answers
12. Covid worked in our favor. Equity culture spread fast and wide across tier 2 and 3 and beyond. We recruited more people. No salary cut. Operating leverage playing out. Legal and audit fees is in line with volume and scale of biz.
13. Will look into it.
Shareholder 4:
Just praises the co.

<EoM>

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Sahil Sharma

Sahil Sharma Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @sahil_vi

1 Jul
#SequentScientific 🐶🐱🐦🦒🦒🦅🐓
Q4 results. My key takeaways:
1. Medium term guidance of mid teen growth and no margin expansion.
Reading b/w the lines:
Co is investing heavily in upgrading and upskilling people, processes, creating capacities all with a focus on changing the terminal value of the business. Trading off Short term pain for long term gain: necessary characteristic for both co & investors.
2. Sequent 2.0 vision: Being executed under guidance of advisory board.
In b/w lines:
Co is upgrading itself from a branded generics player to a specialty branded generics player. Think of a Pikachu to Raichu Evolution.
Evolution takes effort, up front investments. Image
Read 9 tweets
30 Jun
Watched this recent interview of @SamitVartak sir with @PMS_AIF_World. Brilliant interview. Always learn so much from Samit sirs public sharing. My key takeaways:
1. When Samit sir was in US, he spent a lot of time advising manufacturing businesses on how to have a good operating structure limit costs and maximize profits. So his edge is business understanding.
My thoughts:
This is one of the key things I've learned from Samit sir and other fellow investors, it is most important to understand the business and focus on compouding that knowledge by incrementally understanding more businesses rather than get bogged down by valuations.
Read 13 tweets
20 Jun
what better way to start sunday than a #kilpest thread: a classic peter lynch pick & shovel investment for the diagnostics sector. If you like the thread, please retweet this tweet to help educate max investors. 🙏🙏
Before I dive into Kilpest, some words on microcap investing. Everyone **needs** to be aware of what they are signing up for.
Two interviews from @varinder_bansal sir’s Omkara capital with very successful microcap investors (one with @iancassel sir: ...
Read 78 tweets
14 Jun
Which #microcap company should I create the next thread about? Follow the thread to vote!

Please read their screener.in pages and company websites before deciding. I'll also add a few lines for those who don't want to do that.
1. RACL geartech
A precision gear manufacturer (Soma Comstar rings a bell?) supplying to BMW, kubota, Yamaha, KTM. Sticky client relationship built over years. Aiming to grow topline from 180cr to 500cr in next 4 years. Industry leading margins of 15-20%. EV unlikely to disrupt.
Co is also undertaking 50cr capex which is likely to commence soon.
High precision gears are requirement for EV so that noise levels are low since RPM and torque are higher. RACL could benefit on margins whenever clients move to EV.
Read 13 tweets
12 Jun
#neulandlab 🌋🌋 read on to understand this company and its story of transformation. On twitter, 🌋 has become synonymous with neuland, and this is how i will use it throughout the thread. If you like the thread, plz retweet & help fellow investors learn
Starting with a simple primer on the Pharma industry. They make medicines for all of us. The part of the medicine which gives it its potency against the ailment it cures is called API: Active Pharmaceutical Ingredient:
en.wikipedia.org/wiki/Active_in…
(here is a reference few people will get, but have to make it since I love it :D):
If Guardians of the globe (imagecomics.fandom.com/wiki/Guardians…) were a medicine, Omniman (imagecomics.fandom.com/wiki/Nolan_Gra…) is the API.
Read 56 tweets
30 May
#idfcfirstbank is my largest and oldest investment. Thought of creating a thread to explain the business. If you like the thread, please spread the knowledge, retweet. Buckle up, because this is going to be a long one. :D
Quick summary of what a bank does. This enables me to establish a framework under which the analysis of the bank will become very structured.
Money is its raw material.
Bank takes customer deposits, raises money via borrowings (can issue its own bonds, takes loans from other banks etc). This is the input for the bank. Since the bank is liable to pay interest on it, it is also known as liabilities.
Read 66 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(